MedPath
NMPA Approval

Hydroxycarbamide Tablets

国药准字H42022293

July 13, 2020

国药准字H42022293

Drug Information

羟基脲片

片剂

0.25g

化学药品

July 13, 2020

Company Information

Applicant Company

武汉东湖新技术开发区高新二路379号中联药业车间二楼

Manufacturing Company

湖北省武汉市东湖新技术开发区庙山小区特1号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

羟基脲片 - NMPA 批准文号 | MedPath